Record ID | marc_loc_2016/BooksAll.2016.part34.utf8:122776782:3081 |
Source | Library of Congress |
Download Link | /show-records/marc_loc_2016/BooksAll.2016.part34.utf8:122776782:3081?format=raw |
LEADER: 03081cam a22003734a 4500
001 2007017891
003 DLC
005 20090205085829.0
008 070427s2007 njua b 001 0 eng
010 $a 2007017891
016 7 $a101305787$2DNLM
020 $a9780471752158 (cloth)
020 $a0471752150 (cloth)
035 $a(OCoLC)ocn123962939
035 $a(OCoLC)123962939
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dBTCTA$dC#P$dYDXCP$dDLC
042 $apcc
050 00 $aRS420$b.A79 2007
060 10 $aQV 744$bA784 2007
082 00 $a615/.19$222
245 04 $aThe art of drug synthesis /$cedited by Douglas S. Johnson, Jie Jack Li.
260 $aHoboken, N.J. :$bWiley-Interscience,$cc2007.
300 $axv, 276 p. :$bill. ;$c26 cm.
504 $aIncludes bibliographical references and index.
505 0 $aThe role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer : exemestane (Aromasin), anastrozole (Arimidex), and letrozole (Femara) / Jie Jack Li -- Quinolone antibiotics : levofloxacin (Levaquin), moxifloxacin (Avelox), gemifloxacin (Factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals : itraconazole (Sporanox), fluconazole (Diflucan), voriconazole (Vfend), and fosfluconazole (Prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza : oseltamivir phosphate (Tamiflu) and zanamivir (Relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors / Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Piñeiro-Núñez -- GABA receptor agonists for insomnia : zolpidem (Ambien), zaleplon (Sonata), eszopiclone (Estorra, Lunesta), and indiplon / Peter R. Guzzo -- Ligands: neurontin (Gabapentin) and lyrica (Pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder : amphetamine (Adderall), methylphenidate (Ritalin), and atomoxetine (Straterra) / David L. Gray.
650 0 $aDrugs$xDesign.
650 0 $aPharmaceutical chemistry.
650 12 $aDrug Design.
650 22 $aChemistry, Pharmaceutical$xmethods.
700 1 $aJohnson, Douglas S.$q(Douglas Scott),$d1968-
700 1 $aLi, Jie Jack.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0717/2007017891.html
856 42 $3Contributor biographical information$uhttp://www.loc.gov/catdir/enhancements/fy0739/2007017891-b.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0739/2007017891-d.html